MDNYSEServices-HospitalsFiscal year ends December 31

Pediatrix Medical Group, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026

$27.30−0.08 (-0.29%)

Close on Oct 19, 2026

Market cap: $2.22B
P/E (TTM): 13.1
Dividend yield: –

Pediatrix Medical Group, Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31	FY 2007 2007-12-31
Cash & Equivalents	375	230	73	9.82	387	1,124	108	41	40	56	52	48	31	21	19	26	27	14	103
Short-Term Investments	124	119	104	93	100	105	75	22	–	–	–	–	–	6.58	4.14	17	5.38	–	–
Cash & Short-Term Investments	500	349	178	103	487	1,229	182	63	40	56	52	48	31	28	23	44	32	14	103
Receivables	230	260	272	297	302	242	434	507	504	495	445	352	285	248	230	181	164	–	–
Prepaid Expenses & Other	13	13	14	15	19	17	17	17	16	11	9.64	7.04	6.36	4.85	6.31	5.16	5.10	–	–
Other Current Assets	8.88	5.09	12	13	19	62	12	17	37	14	13	7.90	8.01	9.23	7.53	5.24	13	–	–
Total Current Assets	764	640	483	428	841	1,549	732	660	627	587	528	467	368	359	337	296	293	–	–
Property, Plant & Equipment	39	39	76	73	70	76	73	90	124	103	84	66	60	60	61	43	43	–	–
Gross Property, Plant & Equipment	172	166	218	246	235	237	226	271	293	247	203	163	147	134	126	99	–	–	–
Accumulated Depreciation	-132	-127	-143	-172	-165	-160	-153	-181	-170	-144	-119	-97	-87	-74	-65	-56	–	–	–
Land	2.03	2.03	2.03	2.03	2.03	6.68	6.68	6.68	6.68	6.68	6.68	6.68	6.68	6.68	6.68	2.03	–	–	–
Buildings & Improvements	8.29	8.29	8.29	8.29	8.29	27	27	27	33	27	26	23	23	23	22	8.06	–	–	–
Long-Term Investments	–	–	–	–	–	–	0	70	–	–	–	–	–	48	45	27	28	–	–
Operating Lease Right-of-Use Assets	31	34	62	56	51	45	56	0	–	–	–	–	–	–	–	–	–	–	–
Goodwill	1,261	1,243	1,384	1,532	1,505	1,478	1,480	4,061	4,284	3,845	3,366	2,776	2,394	2,166	1,747	1,601	1,270	–	–
Intangible Assets	17	12	21	18	22	27	29	313	640	669	424	198	24	25	–	–	–	–	–
Deferred Tax Assets	74	104	103	106	88	54	87	–	–	–	–	–	–	–	–	–	–	–	–
Other Long-Term Assets	58	77	82	123	131	107	49	81	92	57	82	37	129	118	83	70	55	–	–
Total Assets	2,247	2,153	2,220	2,348	2,723	3,348	4,146	5,937	5,867	5,339	4,547	3,608	3,009	2,750	2,273	2,038	1,689	–	–
Accounts Payable	37	46	35	32	37	60	35	31	35	28	22	33	19	14	12	9.58	346	–	–
Current Portion of Long-Term Debt	27	21	15	15	2.49	–	–	0.25	1.40	20	10	10	0.09	–	–	–	0.23	–	–
Current Debt	27	21	15	15	2.49	–	–	0.25	1.40	20	10	10	0.09	–	–	–	0.23	–	–
Current Portion of Leases	12	13	21	22	20	19	18	0	–	–	–	–	–	–	–	–	–	–	–
Current Income Taxes Payable	0.98	2.17	2.16	16	11	0	6.04	31	92	19	21	25	18	13	20	13	–	–	–
Total Current Liabilities	459	434	389	427	427	444	542	503	531	449	429	416	327	268	254	221	347	–	–
Long-Term Debt	571	597	618	632	–	–	–	–	–	1,679	1,260	557	27	–	–	–	0.21	–	–
Long-Term Leases	26	32	47	44	41	41	45	0	–	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	37	45	68	66	61	60	90	0	–	–	–	–	–	–	–	–	–	–	–
Deferred Tax Liabilities	57	34	34	34	41	62	56	96	148	228	189	160	111	126	94	74	59	–	–
Other Long-Term Liabilities	30	33	31	39	42	45	23	32	58	45	52	59	61	57	55	49	43	–	–
Total Liabilities	1,381	1,388	1,371	1,456	1,826	2,600	2,647	2,850	2,801	2,579	2,109	1,343	666	715	542	590	499	–	–
Total Debt	597	618	633	647	2.49	–	–	0.25	1.40	1,699	1,270	567	27	–	–	–	0.44	–	–
Preferred Stock	0	0	0	0	0	0	0	0	–	–	–	–	0	–	–	–	–	–	–
Common Stock	0.83	0.86	0.84	0.83	0.86	0.86	0.84	0.88	0.94	0.94	0.94	0.96	1.01	1.00	0.49	0.48	0.47	–	–
Additional Paid-In Capital	948	1,014	1,000	984	1,050	1,029	988	993	1,017	974	926	887	858	788	725	659	604	–	–
Retained Earnings	-83	-249	-149	-89	-155	-286	510	2,094	2,048	1,786	1,510	1,377	1,484	1,247	1,006	788	585	–	–
Comprehensive Income & Other	0.61	-1.07	-2.21	-3.74	1.32	3.53	0.08	0	–	–	–	–	–	–	–	–	–	–	–
Shareholders' Equity	866	765	849	892	896	747	1,499	3,088	3,066	2,761	2,438	2,265	2,343	2,035	1,731	1,447	1,190	965	959
Noncontrolling Interest	–	–	–	0	0.21	0.23	0	–	–	–	0.32	0.95	–	–	–	–	–	–	–
Total Equity	866	765	849	892	897	748	1,499	3,088	3,066	2,761	2,438	2,266	2,343	2,035	1,731	1,447	1,190	965	959
Total Liabilities & Equity	2,247	2,153	2,220	2,348	2,723	3,348	4,146	5,937	5,867	5,339	4,547	3,608	3,009	2,750	2,273	2,038	1,689	–	–
Shares Outstanding(shares)	83	86	84	83	86	86	84	88	94	94	94	96	101	100	98	96	94	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: 11.0%
Net margin: 9.0%
Return on equity, FY2025: 20.3%

Financial strength

Current ratio: 1.32
Debt to equity: 0.66
Debt to assets: 27.4%
Cash to current liabilities: 57.6%

Valuation

P/E ratio: 13.1
Price to sales: 1.14
Price to book: 2.52
Dividend yield: –